| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | +58.9% |
| R&D Expense | $20.2M | -24.3% |
| SG&A Expense | $19.7M | -17.6% |
| Operating Income | -$38.3M | +28.1% |
| Interest Expense | $2.9M | -42.6% |
| Income Tax | $0 | — |
| Net Income | -$29.7M | +1.1% |
| EPS (Basic) | -$0.45 | +57.1% |
| EPS (Diluted) | -$0.45 | +57.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.6M | +394.9% |
| Accounts Receivable | $2.0M | — |
| Current Assets | $53.3M | +79.3% |
| Total Assets | $58.6M | +60.0% |
| Current Liabilities | $12.7M | -36.3% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $17.1M | -48.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.7M | +47.3% |
| Capital Expenditures | $88K | -67.2% |
| Investing Cash Flow | -$7.0M | -135.5% |
| Financing Cash Flow | $40.3M | +196.7% |
| Free Cash Flow | -$18.8M | +47.4% |
| $33.0M |
| +1557.1% |